The Effect of CBP on the Immunodeficiency State Induced by Acute Tetramine Poisoning

余晨,刘志红,陈朝红,季大玺,黎磊石
DOI: https://doi.org/10.3969/j.issn.1006-298x.2003.02.004
2003-01-01
Abstract:Objective:To investigate the immune status of the patients with severe tetramine poisoning and the effects of the sequential charcoal hemoperfusion (HP) and continuous blood purification (CBP) treatment on the immune status. Methodology:Twelve patients with severe acute tetramine poisoning were treated by sequential HP and continuous venovenous hemofiltration. Blood were taken from those patients at 0, 12, 24, 48 and 72 hours during CBP. Monocytes were isolated and incubated with LPS 10 μg/ml for 12 hours at 37℃. The levels of TNF α, IL 6 and IL 10 in the supernatants were detected by ELISA method to determine the secreting function of monocytes. The number of monocytes in peripheral blood was also counted at same time. The levels of plasma TNF α, IL 6 and IL 10 were examined simultaneously (ELISA). Results:① Compared with normals, the levels of cytokines secreted from monocytes of tetraminie poisoning patients were significantly lower, especially, the levels of TNF α and IL 10 ( P 0.01).② After HP combined CBP treatment, the concentration of tetramine in blood was decreased markedly( P 0.05), the outcome in most of the patients improved, simultaneously, and the function of monocytes was recovered in those patients( P 0.05). ③ Only in a few patients who failed to recover, the concentration of tetramine in blood was higher than those curing patients, the time from onset of poisoning to HP is later, and the immune status was severely suppressed and couldn't recover. Conclusion:The immune status is severely suppressed in patients with tetramine poisoning. Sequential hemoperfusion and CBP can eliminate the tetramine in blood significantly and persistently, and also improve monocyte function quickly in most of the patients. The prognosis of the poisoning patients is related with the dosage of toxin, the beginning time of treatment and the patient's immune status.
What problem does this paper attempt to address?